Diabetes Care Devices - Angola

  • Angola
  • In Angola, revenue in the Diabetes Care Devices market market is projected to reach US$11.02m in 2024.
  • This revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 12.27%, which will lead to a market volume of US$19.66m by 2029.
  • When compared globally, the highest revenue is anticipated to be generated the United States, amounting to US$11,710.00m in 2024.
  • In Angola, the increasing prevalence of diabetes is driving demand for advanced diabetes care devices, highlighting a critical need for innovation in healthcare solutions.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Angola is witnessing considerable growth, propelled by factors such as increasing prevalence of diabetes, enhanced awareness of disease management, and the availability of advanced monitoring technologies that improve patient outcomes.

Customer preferences:
In Angola, there is a noticeable shift towards personalized diabetes care solutions as consumers become more health-conscious and seek tailored management options. The integration of mobile health applications and telemedicine services has gained traction, enabling users to monitor their glucose levels conveniently. Additionally, younger demographics are increasingly adopting smart devices that provide real-time health data, reflecting a cultural transition towards proactive health management. This trend is further fueled by urbanization and a growing emphasis on preventive care, reshaping the Diabetes Care Devices Market.

Trends in the market:
In Angola, the Diabetes Care Devices Market is experiencing a significant shift towards innovative and personalized solutions, driven by an increasing health consciousness among consumers. Mobile health applications are becoming essential tools for diabetes management, enabling users to conveniently track glucose levels and receive real-time feedback. Furthermore, younger populations are embracing smart devices that offer continuous health monitoring, reflecting a cultural shift towards proactive health management. This evolution is supported by urbanization and a growing focus on preventive care, presenting opportunities for industry stakeholders to develop tailored products and services that meet the demands of this emerging market.

Local special circumstances:
In Angola, the Diabetes Care Devices Market is shaped by a unique blend of geographical and cultural factors that influence its dynamics. The country's diverse terrain and limited healthcare infrastructure create challenges for diabetes management, particularly in rural areas. However, urban centers are witnessing a surge in health awareness, leading to increased demand for diabetes care solutions. Additionally, local cultural practices emphasize community health, fostering acceptance of innovative technologies. Regulatory support for medical devices is gradually improving, encouraging investments and the introduction of tailored diabetes care solutions that resonate with the population's needs.

Underlying macroeconomic factors:
The Diabetes Care Devices Market in Angola is significantly influenced by macroeconomic factors such as national economic stability, investment in healthcare infrastructure, and global economic trends. Angola's ongoing economic recovery, driven by oil revenues and increased foreign investment, is fostering improvements in healthcare access and technology adoption. Moreover, fiscal policies aimed at enhancing public health spending are facilitating the introduction of innovative diabetes care solutions. The rising incidence of diabetes, coupled with a growing awareness of the disease, is driving demand for effective management devices, while global partnerships and collaborations in medical technology are further enhancing local capabilities and market growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)